11 February 2016
Prostate cancer diagnosis could become easier and more effective in future thanks to a new gas chromatography sensor system with the ability to "sniff out" the disease.
Developed by the University of Liverpool, the Odoreader diagnostic test circumvents the need for invasive and potentially unnecessary biopsies by identifying telltale patterns of volatile compounds in urine samples.
A pilot study was recently concluded involving 155 men presenting to urology clinics, of whom 58 were diagnosed with prostate cancer, 24 with bladder cancer and 73 with haematuria or poor stream without cancer.
The gas chromatography sensor system was shown to be able to successfully identify different urine profile patterns, allowing patients with urological cancers to be successfully categorised.
Professor Chris Probert from the University of Liverpool's Institute of Translational Medicine said: "With help from industry partners, we will be able to further develop the Odoreader, which will enable it to be used where it is needed most: at a patient's bedside, in a doctor's surgery, in a clinic or walk-in centre."
Currently, there is no accurate test for prostate cancer. The availability of this test could allow the disease to be diagnosed earlier and treated more successfully.
Posted by Edward Bartel
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.